TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 17161520

Group type: EXPERIMENTAL
Intervention: Active surveillance
Number of subjects: 278
Study: 14994690

Group type: EXPERIMENTAL
Intervention: Decision analysis (computerised utility assessment interview with individualised risk assessment and decision analysis)
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Video plus leaflet
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Decision analysis plus video plus leaflet
Number of subjects: 217

Group type: COMPARATOR
Intervention: No decision analysis
Number of subjects: 217

Group type: COMPARATOR
Intervention: No video plus leaflet
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Decision analysis and video plus leaflet interaction
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Decision analysis
Number of subjects: 217
Study: 11320899

Group type: EXPERIMENTAL
Intervention: 300 micrograms GM‐CSF in a 2% methylcellulose gel daily
Number of subjects: 36

Group type: COMPARATOR
Intervention: 2% methylcellulose gel alone (placebo)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: GM‐CSF group
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 36
Study: 9129083

Group type: EXPERIMENTAL
Intervention: Granulocyte colony-stimulating factor (G-CSF), daily treatment over a 14-day period.
Number of subjects: 0
Study: 8179852

Group type: EXPERIMENTAL
Intervention: lacidipine
Number of subjects: 18

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 18
Study: 31982355

Group type: EXPERIMENTAL
Intervention: Follitropin epsilon 75 IU daily
Number of subjects: 247

Group type: EXPERIMENTAL
Intervention: Follitropin epsilon 112.5 IU
Number of subjects: 247

Group type: COMPARATOR
Intervention: Follitropin alfa 150 IU daily
Number of subjects: 247
Study: 31493887

Group type: EXPERIMENTAL
Intervention: Peanut sublingual immunotherapy (SLIT) with 2 mg/d peanut protein for up to 5 years
Number of subjects: 48
Study: 27789240

Group type: EXPERIMENTAL
Intervention: 4-week standardized, hospital-based rehabilitation program followed by a personalized, self-managed, home-based rehabilitation program
Number of subjects: 21
Study: 26788484

Group type: EXPERIMENTAL
Intervention: BTX-A injection + EMG biofeedback
Number of subjects: 34

Group type: COMPARATOR
Intervention: Normal saline + EMG biofeedback
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Both groups (BTX-A and control)
Number of subjects: 34
Study: 23338814

Group type: EXPERIMENTAL
Intervention: Sublingual isosorbide dinitrate, 5 mg (N‐EST)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control EST (C‐EST)
Number of subjects: 53
Study: 21146572

Group type: EXPERIMENTAL
Intervention: 5 g scFOS
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 8 g scFOS
Number of subjects: 20

Group type: COMPARATOR
Intervention: 0 g scFOS (control)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Breath hydrogen measures
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Gastrointestinal tolerance evaluation
Number of subjects: 20
Study: 18271887

Group type: EXPERIMENTAL
Intervention: Medical treatment (misoprostol vaginally)
Number of subjects: 652

Group type: COMPARATOR
Intervention: Surgical treatment (vacuum aspiration)
Number of subjects: 652
Study: 16487998

Group type: EXPERIMENTAL
Intervention: School-based smoking prevention curriculum with a social normative approach
Number of subjects: 7

Group type: COMPARATOR
Intervention: Control group (matched schools)
Number of subjects: 7
Study: 12764372

Group type: EXPERIMENTAL
Intervention: AIDA protocol (all-trans retinoic acid and idarubicin)
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: AIDA protocol (consolidation therapy)
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: amended AIDA protocol (aAIDA)
Number of subjects: 134

Group type: COMPARATOR
Intervention: AIDA protocol
Number of subjects: 134
Study: 11109030

Group type: EXPERIMENTAL
Intervention: Protocol A (paramedics operating protocol A)
Number of subjects: 1309

Group type: COMPARATOR
Intervention: Protocol B (paramedics operating protocol B)
Number of subjects: 1309

Group type: EXPERIMENTAL
Intervention: Protocol A
Number of subjects: 1309

Group type: COMPARATOR
Intervention: Protocol B
Number of subjects: 1309
Study: 9186434

Group type: EXPERIMENTAL
Intervention: Photorefractive keratectomy (PRK)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Contralateral eyes (control)
Number of subjects: 111
Study: 1550219

Group type: EXPERIMENTAL
Intervention: Resistance training plus growth hormone (GH)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Resistance training plus placebo
Number of subjects: 16
Study: 2859841

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation (TENS)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Sham stimulator setups
Number of subjects: 24
Study: 30838389

Group type: EXPERIMENTAL
Intervention: TPB based education program
Number of subjects: 140

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 140
Study: 30144888

Group type: EXPERIMENTAL
Intervention: Jelly filled doughnut with water consumed 30 minutes after the doughnut (Group B)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Jelly filled doughnut with water consumed 30 minutes before the doughnut (Group C)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Jelly filled doughnut with water consumed 30 minutes after the first doughnut (Group D)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Jelly filled doughnut with water consumed 30 minutes after the first doughnut (Group E)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Jelly filled doughnut without water (Group A)
Number of subjects: 35
Study: 26802917

Group type: EXPERIMENTAL
Intervention: Coaching group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Self‐directed learning group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 0
Study: 25043862

Group type: EXPERIMENTAL
Intervention: Amiodarone-releasing hydrogel applied epicardially
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no amiodarone hydrogel)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Amiodarone-releasing hydrogel
Number of subjects: 100
Study: 23469596

Group type: EXPERIMENTAL
Intervention: Electro-acupuncture combined with general intravenous anesthesia (Group D)
Number of subjects: 40

Group type: COMPARATOR
Intervention: General intravenous anesthesia (Group N)
Number of subjects: 40
Study: 20406937

Group type: EXPERIMENTAL
Intervention: Granulocyte colony-stimulating factor (G-CSF) treatment after induction in patients overexpressing G-CSFR isoform IV
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Granulocyte colony-stimulating factor (G-CSF) treatment after induction
Number of subjects: 154

Group type: COMPARATOR
Intervention: No G-CSF treatment
Number of subjects: 154
Study: 17276748

Group type: EXPERIMENTAL
Intervention: DD‐CGAS
Number of subjects: 83
Study: 16318774

Group type: EXPERIMENTAL
Intervention: TPN including GLN dipeptide
Number of subjects: 40

Group type: COMPARATOR
Intervention: TPN
Number of subjects: 40
Study: 12040303

Group type: EXPERIMENTAL
Intervention: Walk-and-talk group (30 min, 5 times per week for 16 weeks, walking/talking in pairs)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Talk-only group (30 min, 5 times per week for 16 weeks, talk only in pairs)
Number of subjects: 3

Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 3
Study: 10215749

Group type: EXPERIMENTAL
Intervention: Intravenous L-arginine (30 g over 30 min)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Oral L-arginine (10 g)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control study (normal diet, n = 12)
Number of subjects: 10
Study: 8592593

Group type: EXPERIMENTAL
Intervention: Isolated ultrafiltration at 35.0 degrees C
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Combined ultrafiltration-haemodialysis at 37.5 degrees C
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Combined ultrafiltration-haemodialysis at 35.0 degrees C
Number of subjects: 12

Group type: COMPARATOR
Intervention: Combined ultrafiltration-haemodialysis at both temperatures
Number of subjects: 12
Study: 2092028

Group type: EXPERIMENTAL
Intervention: Sucralfate 1 gm T.D.S. one hour before meal and 1 gm nocte
Number of subjects: 66

Group type: COMPARATOR
Intervention: Ranitidine 300 mg nocte
Number of subjects: 66
Study: 328526

Group type: EXPERIMENTAL
Intervention: R-75 strain live, attenuated, serum inhibitor-resistant influenza B vaccine
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo solution
Number of subjects: 21
Study: 31483963

Group type: EXPERIMENTAL
Intervention: Inhaled recombinant human GM-CSF (sargramostim), 125 μg twice daily for 7 days, every other week for 24 weeks
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Inhaled recombinant human GM-CSF (sargramostim)
Number of subjects: 64
Study: 28599016

Group type: EXPERIMENTAL
Intervention: Specific Strength Training (SST)
Number of subjects: 23

Group type: COMPARATOR
Intervention: General Fitness Training (GFT)
Number of subjects: 23
Study: 25952547

Group type: EXPERIMENTAL
Intervention: Hatha yoga intervention (8-week, twice-weekly)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Waitlist control condition
Number of subjects: 52
Study: 23374364

Group type: EXPERIMENTAL
Intervention: PES (previous ERCP with ES)
Number of subjects: 176

Group type: COMPARATOR
Intervention: NPES (no previous intervention)
Number of subjects: 176
Study: 21340026

Group type: EXPERIMENTAL
Intervention: Sorafenib therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 19326174

Group type: EXPERIMENTAL
Intervention: 5 mg diazepam, given orally 1 hour before 18F-FDG injection
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 17595888

Group type: EXPERIMENTAL
Intervention: RNF1
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: RNF2
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: R (current formulation)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 12617708

Group type: EXPERIMENTAL
Intervention: Beta carotene (50 mg on alternate days)
Number of subjects: 22071

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22071
Study: 10678541

Group type: EXPERIMENTAL
Intervention: Atenolol (100 mg/day)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Bisoprolol (10 mg/day)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 9164806

Group type: EXPERIMENTAL
Intervention: Standard BP measurement protocol (ensuring restful state, proper positioning, and quiet time)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Standard BP measurement protocol
Number of subjects: 64

Group type: COMPARATOR
Intervention: Routine nurse measurements
Number of subjects: 64
Study: 8455331

Group type: EXPERIMENTAL
Intervention: Cefpodoxime (CPDX-PR) given orally twice a day at 100-200 mg for 5-21 days
Number of subjects: 61
Study: 3764230

Group type: EXPERIMENTAL
Intervention: Test handwashing protocol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard handwashing protocol
Number of subjects: 0
Study: 31732867

Group type: EXPERIMENTAL
Intervention: Pre-operative meloxicam administration
Number of subjects: 196

Group type: COMPARATOR
Intervention: Post-operative meloxicam administration
Number of subjects: 196
Study: 30754668

Group type: EXPERIMENTAL
Intervention: HY-coated implants
Number of subjects: 106

Group type: COMPARATOR
Intervention: Control implants
Number of subjects: 106
Study: 30103509

Group type: EXPERIMENTAL
Intervention: Higher Protein Diet (HP)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Higher Carbohydrate Diet (HC)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Exercise-only group (E)
Number of subjects: 54
Study: 26486682

Group type: EXPERIMENTAL
Intervention: Postoperative exercise program
Number of subjects: 69

Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 69
Study: 24684867

Group type: EXPERIMENTAL
Intervention: Single-incision laparoscopic surgery (SILS)
Number of subjects: 75

Group type: COMPARATOR
Intervention: 3-port laparoscopic surgery
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 75
Study: 21765343

Group type: EXPERIMENTAL
Intervention: 6-week educational program on memory training, physical activity, stress reduction, and healthy diet
Number of subjects: 115
Study: 19631843

Group type: EXPERIMENTAL
Intervention: Endodontic surgical procedures
Number of subjects: 0
Study: 17956196

Group type: EXPERIMENTAL
Intervention: Alendronate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Risedronate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Raloxifene
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ibandronate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Strontium
Number of subjects: 0

Group type: COMPARATOR
Intervention: Parathyroid hormone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ibandronate (intermittent intravenous administration)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Zoledronate (intermittent intravenous administration)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Denosumab (subcutaneous administration)
Number of subjects: 0
Study: 15259827

Group type: EXPERIMENTAL
Intervention: Brief educational and advice support service
Number of subjects: 106

Group type: COMPARATOR
Intervention: Usual care from community psychiatric services
Number of subjects: 106
Study: 12454533

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 10567777

Group type: EXPERIMENTAL
Intervention: Ceftriaxone plus aminoglycoside with filgrastim (once daily for > or =5 days, > or =2 days, and until ANC > or =1.0x10(9)/l for 2 days)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Out-patient treatment (early discharge)
Number of subjects: 105
Study: 7600120

Group type: EXPERIMENTAL
Intervention: recombinant hirudin (HBW 023, 0.35 mg/kg body wt SC)
Number of subjects: 15

Group type: COMPARATOR
Intervention: unfractionated heparin (UFH, HeparinNovo; 150 IU/kg body wt SC)
Number of subjects: 15

Group type: COMPARATOR
Intervention: low-molecular-weight heparin (LMWH, Fragmin; 75 IU/kg body wt SC)
Number of subjects: 15
Study: 2204661

Group type: EXPERIMENTAL
Intervention: Branched-chain amino acids (0.24 g/kg)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Casein (equinitrogenous amount)
Number of subjects: 64
Study: 678831

Group type: EXPERIMENTAL
Intervention: 60 mg/kg oxamniquine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 40 mg/kg oxamniquine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 30 mg/kg oxamniquine
Number of subjects: 0
Study: 30649485

Group type: EXPERIMENTAL
Intervention: Computed tomography (CT)‐based image‐guided brachytherapy (IGBT) with whole‐pelvic radiotherapy and concurrent chemotherapy (76% of patients)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Computed tomography (CT)‐based image‐guided brachytherapy (IGBT)
Number of subjects: 84
Study: 27377577

Group type: EXPERIMENTAL
Intervention: IMAGE intervention (Improving Mothers' parenting Abilities, Growth, and Effectiveness)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Standard care control condition
Number of subjects: 124
Study: 26200143

Group type: EXPERIMENTAL
Intervention: 5.25% sodium hypochlorite (NaOCl)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: 2% chlorhexidine (CHX) gel
Number of subjects: 62
Study: 23172172

Group type: EXPERIMENTAL
Intervention: PRT-201 (0.0033 to 9 mg)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: PRT-201 (Low Dose)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study: 21132439

Group type: EXPERIMENTAL
Intervention: High carbohydrate state (CHO)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Fasted state (F)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both groups (F and CHO)
Number of subjects: 20
Study: 19709723

Group type: EXPERIMENTAL
Intervention: OC-PA (Organic Contamination with Phosphoric Acid cleaning)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: IC-FU (Inorganic Contamination with Furnace cleaning)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: OC+IC-PA+FU (Organic and Inorganic Contamination with both cleaning methods)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: OC+IC-no cleaning (Organic and Inorganic Contamination with no cleaning)
Number of subjects: 100

Group type: COMPARATOR
Intervention: no contamination-no cleaning (Control group)
Number of subjects: 100
Study: 17286730

Group type: EXPERIMENTAL
Intervention: Community hospital care
Number of subjects: 13
Study: 15534121

Group type: EXPERIMENTAL
Intervention: Surgery
Number of subjects: 225

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Surgery (subgroup with visual acuity worse than 20/100)
Number of subjects: 225
Study: 11292293

Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF) combined with cyclosporin (CyA) and steroids (Pred)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Historic azathioprine (AZA) group (CyA, Pred, and azathioprine)
Number of subjects: 65
Study: 9480238

Group type: EXPERIMENTAL
Intervention: Nonpregnant women with RSA
Number of subjects: 117

Group type: COMPARATOR
Intervention: Healthy nonpregnant multigravidas (control)
Number of subjects: 117
Study: 7894531

Group type: EXPERIMENTAL
Intervention: Ointment containing 2-chloroethyl-3-chloropropyl sulfide (CLEPS) applied topically
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (normal control)
Number of subjects: 0
Study: 6146346

Group type: EXPERIMENTAL
Intervention: Astemizole, 10 mg
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study: 30639252

Group type: EXPERIMENTAL
Intervention: WP pre‐RT
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: WP post‐RT
Number of subjects: 70

Group type: COMPARATOR
Intervention: PLA pre and post‐RT
Number of subjects: 70
Study: 30158068

Group type: EXPERIMENTAL
Intervention: On-pump CABG
Number of subjects: 100

Group type: COMPARATOR
Intervention: Off-pump CABG
Number of subjects: 100
Study: 25162653

Group type: EXPERIMENTAL
Intervention: Inspiratory-loaded core training (ICT)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control condition (CON)
Number of subjects: 16
Study: 25006718

Group type: EXPERIMENTAL
Intervention: Letrozole
Number of subjects: 750

Group type: COMPARATOR
Intervention: Clomiphene
Number of subjects: 750
Study: 22113536

Group type: EXPERIMENTAL
Intervention: Cold environment (7°C)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Room temperature (20°C)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Hot environment (33°C)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Exercise (1 h cycling at 60% Wmax)
Number of subjects: 9
Study: 20395821

Group type: EXPERIMENTAL
Intervention: Intrathecal ketorolac (2.0 mg)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Intravenous ketorolac
Number of subjects: 41
Study: 17425549

Group type: EXPERIMENTAL
Intervention: Hydrofiber Ag dressing
Number of subjects: 67

Group type: COMPARATOR
Intervention: povidone-iodine gauze
Number of subjects: 67
Study: 17092241

Group type: EXPERIMENTAL
Intervention: Emdogain alone
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Emdogain + beta-TCP
Number of subjects: 56

Group type: COMPARATOR
Intervention: Modified Widman flap (MWF)
Number of subjects: 56
Study: 15243302

Group type: EXPERIMENTAL
Intervention: Intravenous treprostinil sodium (10 ng/kg/min for 72 hours)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Subcutaneous treprostinil sodium (10 ng/kg/min for 72 hours)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Intravenous treprostinil sodium
Number of subjects: 51

Group type: COMPARATOR
Intervention: Subcutaneous treprostinil sodium
Number of subjects: 51
Study: 11341175

Group type: EXPERIMENTAL
Intervention: Maternal serum natural antibodies (N‐Ab) of IgG class to proteins MBP, S100, ACBP14/18 and MP65
Number of subjects: 1987

Group type: EXPERIMENTAL
Intervention: Abnormally high and low reactivity of maternal N‐Ab
Number of subjects: 1987
Study: 8861797

Group type: EXPERIMENTAL
Intervention: Azathioprine after cessation of CsA
Number of subjects: 12

Group type: COMPARATOR
Intervention: CsA continued (Control)
Number of subjects: 12
Study: 1386977

Group type: EXPERIMENTAL
Intervention: Ondansetron injection (4 mg once daily by intravenous administration for 3-5 consecutive days)
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Ondansetron injection
Number of subjects: 207
Study: 6370637

Group type: EXPERIMENTAL
Intervention: Timolol maleate 0.50% (short-term trial)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Timolol maleate 0.50% or 0.25% (long-term trial)
Number of subjects: 30
Study: 30813758

Group type: EXPERIMENTAL
Intervention: CTO-PCI
Number of subjects: 834

Group type: COMPARATOR
Intervention: No CTO-PCI
Number of subjects: 834
Study: 28267236

Group type: EXPERIMENTAL
Intervention: 20 mg/day vonoprazan for 8 weeks
Number of subjects: 92
Study: 25950747

Group type: EXPERIMENTAL
Intervention: Left-lateralised children
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Greater variability in lateralised response
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Delayed establishment of language specialisation
Number of subjects: 58

Group type: COMPARATOR
Intervention: Right- and bi-lateralised children
Number of subjects: 58
Study: 24053577

Group type: EXPERIMENTAL
Intervention: Auricular acupuncture treatment two times per week for 4 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Usual care (no acupuncture treatment)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Auricular acupuncture treatment
Number of subjects: 60
Study: 21427394

Group type: EXPERIMENTAL
Intervention: Supervised intake of artemether-lumefantrine
Number of subjects: 359

Group type: EXPERIMENTAL
Intervention: Unsupervised intake of artemether-lumefantrine
Number of subjects: 359

Group type: EXPERIMENTAL
Intervention: Both supervised and unsupervised intake of artemether-lumefantrine
Number of subjects: 359
Study: 19266389

Group type: EXPERIMENTAL
Intervention: GPLC-1 (1g PLC/d)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: GPLC-3 (3g PLC/d)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Anaerobic exercise
Number of subjects: 32
Study: 16950986

Group type: EXPERIMENTAL
Intervention: Neonatal indomethacin treatment
Number of subjects: 47

Group type: COMPARATOR
Intervention: Saline control
Number of subjects: 47